Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Neoplasms of the CNS

Free Subscription Articles published in Clin Cancer Res Retrieve available abstracts of 113 articles: HTML format

Single Articles

May 2009
1. HERVOUET E , Debien E, Campion L, Charbord J, et al
   Folate Supplementation Limits the Aggressiveness of Glioma via the Remethylation of DNA Repeats Element and Genes Governing Apoptosis and Proliferation.
   Clin Cancer Res. 2009;15:3519-29.
   PubMed     Related articles    Abstract available
   
   
   
2. GUILLAMO JS , de Bouard S, Valable S, Marteau L, et al
   Molecular Mechanisms Underlying Effects of Epidermal Growth Factor Receptor Inhibition on Invasion, Proliferation, and Angiogenesis in Experimental Glioma.
   Clin Cancer Res. 2009.
   PubMed     Related articles    Abstract available
   
   
   
3. KREISL TN , Kim L, Moore K, Duic P, et al
   A Phase I Trial of Enzastaurin in Patients with Recurrent Gliomas.
   Clin Cancer Res. 2009.
   PubMed     Related articles    Abstract available
   
   
   
4. SCHMIDT AL , de Farias CB, Abujamra AL, Brunetto AL, et al
   Phosphodiesterase-4 inhibition and brain tumor growth.
   Clin Cancer Res. 2009;15:3238.
   PubMed     Related articles   
   
   
   April 2009
5. AZIZ SA , Davies M, Pick E, Zito C, et al
   Phosphatidylinositol-3-Kinase as a Therapeutic Target in Melanoma.
   Clin Cancer Res. 2009.
   PubMed     Related articles    Abstract available
   
   
   
6. HORIGUCHI K , Yamada M, Satoh T, Hashimoto K, et al
   Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue.
   Clin Cancer Res. 2009;15:2620-9.
   PubMed     Related articles    Abstract available
   
   
   
7. LUN XQ , Jang JH, Tang N, Deng H, et al
   Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide.
   Clin Cancer Res. 2009.
   PubMed     Related articles    Abstract available
   
   
   March 2009
8. KADOCH C , Dinca EB, Voicu R, Chen L, et al
   Pathologic correlates of primary central nervous system lymphoma defined in an orthotopic xenograft model.
   Clin Cancer Res. 2009;15:1989-97.
   PubMed     Related articles    Abstract available
   
   
   
9. GARRE ML , Cama A, Bagnasco F, Morana G, et al
   Medulloblastoma Variants: Age-Dependent Occurrence and Relation to Gorlin Syndrome--A New Clinical Perspective.
   Clin Cancer Res. 2009.
   PubMed     Related articles    Abstract available
   
   
   
10. CAO Y , Tsien CI, Sundgren PC, Nagesh V, et al
    Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for prediction of radiation-induced neurocognitive dysfunction.
    Clin Cancer Res. 2009;15:1747-54.
    PubMed     Related articles    Abstract available
    
    
    February 2009
11. LIN NU , Dieras V, Paul D, Lossignol D, et al
    Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer.
    Clin Cancer Res. 2009;15:1452-1459.
    PubMed     Related articles    Abstract available
    
    
    
12. WRAGE M , Ruosaari S, Eijk PP, Kaifi JT, et al
    Genomic Profiles Associated with Early Micrometastasis in Lung Cancer: Relevance of 4q Deletion.
    Clin Cancer Res. 2009.
    PubMed     Related articles    Abstract available
    
    
    
13. BENNY O , Menon LG, Ariel G, Goren E, et al
    Local Delivery of Poly Lactic-co-glycolic Acid Microspheres Containing Imatinib Mesylate Inhibits Intracranial Xenograft Glioma Growth.
    Clin Cancer Res. 2009.
    PubMed     Related articles    Abstract available
    
    
    
14. GRINBERG-RASHI H , Ofek E, Perelman M, Skarda J, et al
    The Expression of Three Genes in Primary Non-Small Cell Lung Cancer Is Associated with Metastatic Spread to the Brain.
    Clin Cancer Res. 2009.
    PubMed     Related articles    Abstract available
    
    
    
15. QUINN JA , Jiang SX, Carter J, Reardon DA, et al
    Phase II Trial of Gliadel plus O6-Benzylguanine in Adults with Recurrent Glioblastoma Multiforme.
    Clin Cancer Res. 2009;15:1064-8.
    PubMed     Related articles    Abstract available
    
    
    
16. MIYASHITA K , Kawakami K, Nakada M, Mai W, et al
    Potential Therapeutic Effect of Glycogen Synthase Kinase 3{beta} Inhibition against Human Glioblastoma.
    Clin Cancer Res. 2009;15:887-897.
    PubMed     Related articles    Abstract available
    
    
    January 2009
17. BRONISCER A , Baker SJ, Stewart CF, Merchant TE, et al
    Phase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade glioma.
    Clin Cancer Res. 2009;15:701-7.
    PubMed     Related articles    Abstract available
    
    
    
18. RUSSO AL , Kwon HC, Burgan WE, Carter D, et al
    In vitro and In vivo Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016.
    Clin Cancer Res. 2009;15:607-12.
    PubMed     Related articles    Abstract available
    
    
    
19. KESARI S , Schiff D, Drappatz J, Lafrankie D, et al
    Phase II Study of Protracted Daily Temozolomide for Low-Grade Gliomas in Adults.
    Clin Cancer Res. 2009;15:330-337.
    PubMed     Related articles    Abstract available
    
    
    
20. LIU TF , Cai J, Gibo DM, Debinski W, et al
    Reoxygenation of hypoxic glioblastoma multiforme cells potentiates the killing effect of an interleukin-13-based cytotoxin.
    Clin Cancer Res. 2009;15:160-8.
    PubMed     Related articles    Abstract available
    
    
    December 2008
21. ABOU-GHAZAL M , Yang DS, Qiao W, Reina-Ortiz C, et al
    The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human Gliomas.
    Clin Cancer Res. 2008;14:8228-8235.
    PubMed     Related articles    Abstract available
    
    
    
22. PALLINI R , Ricci-Vitiani L, Banna GL, Signore M, et al
    Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.
    Clin Cancer Res. 2008;14:8205-12.
    PubMed     Related articles    Abstract available
    
    
    
23. GOLDHOFF P , Warrington NM, Limbrick DD Jr, Hope A, et al
    Targeted Inhibition of Cyclic AMP Phosphodiesterase-4 Promotes Brain Tumor Regression.
    Clin Cancer Res. 2008;14:7717-7725.
    PubMed     Related articles    Abstract available
    
    
    
24. MCDONALD JM , Pelloski CE, Ledoux A, Sun M, et al
    Elevated phospho-S6 expression is associated with metastasis in adenocarcinoma of the lung.
    Clin Cancer Res. 2008;14:7832-7.
    PubMed     Related articles    Abstract available
    
    
    
25. MARSH J , Mukherjee P, Seyfried TN
    Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma.
    Clin Cancer Res. 2008;14:7751-62.
    PubMed     Related articles    Abstract available
    
    
    November 2008
26. VEERAVAGU A , Liu Z, Niu G, Chen K, et al
    Integrin {alpha}v{beta}3-Targeted Radioimmunotherapy of Glioblastoma Multiforme.
    Clin Cancer Res. 2008;14:7330-7339.
    PubMed     Related articles    Abstract available
    
    
    
27. DESJARDINS A , Reardon DA, Herndon JE 2nd, Marcello J, et al
    Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas.
    Clin Cancer Res. 2008;14:7068-73.
    PubMed     Related articles    Abstract available
    
    
    
28. GUERREIRO AS , Fattet S, Fischer B, Shalaby T, et al
    Targeting the PI3K p110{alpha} Isoform Inhibits Medulloblastoma Proliferation, Chemoresistance, and Migration.
    Clin Cancer Res. 2008;14:6761-9.
    PubMed     Related articles    Abstract available
    
    
    
29. LI J , Guan HY, Gong LY, Song LB, et al
    Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival.
    Clin Cancer Res. 2008;14:6996-7003.
    PubMed     Related articles    Abstract available
    
    
    October 2008
30. SCHEURER ME , Amirian E, Cao Y, Gilbert MR, et al
    Polymorphisms in the Interleukin-4 Receptor Gene are Associated with Better Survival in Patients with Glioblastoma.
    Clin Cancer Res. 2008;14:6640-6.
    PubMed     Related articles    Abstract available
    
    
    
31. LO HW , Cao X, Zhu H, Ali-Osman F, et al
    Constitutively Activated STAT3 Frequently Coexpresses with Epidermal Growth Factor Receptor in High-Grade Gliomas and Targeting STAT3 Sensitizes Them to Iressa and Alkylators.
    Clin Cancer Res. 2008;14:6042-54.
    PubMed     Related articles    Abstract available
    
    
    September 2008
32. KONG LY , Abou-Ghazal MK, Wei J, Chakraborty A, et al
    A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells.
    Clin Cancer Res. 2008;14:5759-68.
    PubMed     Related articles    Abstract available
    
    
    
33. XIONG Z , Gharagozlou S, Vengco I, Chen W, et al
    Effective CpG Immunotherapy of Breast Carcinoma Prevents but Fails to Eradicate Established Brain Metastasis.
    Clin Cancer Res. 2008;14:5484-5493.
    PubMed     Related articles    Abstract available
    
    
    
34. MARTENS T , Laabs Y, Gunther HS, Kemming D, et al
    Inhibition of Glioblastoma Growth in a Highly Invasive Nude Mouse Model Can Be Achieved by Targeting Epidermal Growth Factor Receptor but not Vascular Endothelial Growth Factor Receptor-2.
    Clin Cancer Res. 2008;14:5447-58.
    PubMed     Related articles    Abstract available
    
    
    
35. CHINNAIYAN P , Cerna D, Burgan WE, Beam K, et al
    Postradiation sensitization of the histone deacetylase inhibitor valproic acid.
    Clin Cancer Res. 2008;14:5410-5.
    PubMed     Related articles    Abstract available
    
    
    August 2008
36. HEIMBERGER AB , Abou-Ghazal M, Reina-Ortiz C, Yang DS, et al
    Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human Gliomas.
    Clin Cancer Res. 2008;14:5166-5172.
    PubMed     Related articles    Abstract available
    
    
    
37. BARBIERI F , Bajetto A, Stumm R, Pattarozzi A, et al
    Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas.
    Clin Cancer Res. 2008;14:5022-32.
    PubMed     Related articles    Abstract available
    
    
    
38. MAXWELL JA , Johnson SP, McLendon RE, Lister DW, et al
    Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma.
    Clin Cancer Res. 2008;14:4859-68.
    PubMed     Related articles    Abstract available
    
    
    
39. BRANTLEY EC , Nabors LB, Gillespie GY, Choi YH, et al
    Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression.
    Clin Cancer Res. 2008;14:4694-704.
    PubMed     Related articles    Abstract available
    
    
    
40. LUDWIG N , Keller A, Comtesse N, Rheinheimer S, et al
    Pattern of serum autoantibodies allows accurate distinction between a tumor and pathologies of the same organ.
    Clin Cancer Res. 2008;14:4767-74.
    PubMed     Related articles    Abstract available
    
    
    July 2008
41. DE HAAS T , Hasselt N, Troost D, Caron H, et al
    Molecular Risk Stratification of Medulloblastoma Patients Based on Immunohistochemical Analysis of MYC, LDHB, and CCNB1 Expression.
    Clin Cancer Res. 2008;14:4154-60.
    PubMed     Related articles    Abstract available
    
    
    
42. NAM DH , Jeon HM, Kim S, Kim MH, et al
    Activation of Notch Signaling in a Xenograft Model of Brain Metastasis.
    Clin Cancer Res. 2008;14:4059-4066.
    PubMed     Related articles    Abstract available
    
    
    
43. HUANG J , Grotzer MA, Watanabe T, Hewer E, et al
    Mutations in the nijmegen breakage syndrome gene in medulloblastomas.
    Clin Cancer Res. 2008;14:4053-8.
    PubMed     Related articles    Abstract available
    
    
    June 2008
44. YIN D , Wang X, Konda BM, Ong JM, et al
    Increase in brain tumor permeability in glioma-bearing rats with nitric oxide donors.
    Clin Cancer Res. 2008;14:4002-9.
    PubMed     Related articles    Abstract available
    
    
    
45. YANG L , Clarke MJ, Carlson BL, Mladek AC, et al
    PTEN Loss Does Not Predict for Response to RAD001 (Everolimus) in a Glioblastoma Orthotopic Xenograft Test Panel.
    Clin Cancer Res. 2008;14:3993-4001.
    PubMed     Related articles    Abstract available
    
    
    
46. LAZOVIC J , Jensen MC, Ferkassian E, Aguilar B, et al
    Imaging Immune Response In vivo: Cytolytic Action of Genetically Altered T Cells Directed to Glioblastoma Multiforme.
    Clin Cancer Res. 2008;14:3832-3839.
    PubMed     Related articles    Abstract available
    
    
    
47. WEI LH , Su H, Hildebrandt IJ, Phelps ME, et al
    Changes in tumor metabolism as readout for Mammalian target of rapamycin kinase inhibition by rapamycin in glioblastoma.
    Clin Cancer Res. 2008;14:3416-26.
    PubMed     Related articles    Abstract available
    
    
    
48. THORARINSDOTTIR HK , Santi M, McCarter R, Rushing EJ, et al
    Protein Expression of Platelet-Derived Growth Factor Receptor Correlates with Malignant Histology and PTEN with Survival in Childhood Gliomas.
    Clin Cancer Res. 2008;14:3386-94.
    PubMed     Related articles    Abstract available
    
    
    May 2008
49. EGLER V , Korur S, Failly M, Boulay JL, et al
    Histone deacetylase inhibition and blockade of the glycolytic pathway synergistically induce glioblastoma cell death.
    Clin Cancer Res. 2008;14:3132-40.
    PubMed     Related articles    Abstract available
    
    
    
50. DE VLEESCHOUWER S , Fieuws S, Rutkowski S, Van Calenbergh F, et al
    Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme.
    Clin Cancer Res. 2008;14:3098-104.
    PubMed     Related articles    Abstract available
    
    
    
51. REDDY SP , Britto R, Vinnakota K, Aparna H, et al
    Novel Glioblastoma Markers with Diagnostic and Prognostic Value Identified through Transcriptome Analysis.
    Clin Cancer Res. 2008;14:2978-87.
    PubMed     Related articles    Abstract available
    
    
    
52. SARKARIA JN , Kitange GJ, James CD, Plummer R, et al
    Mechanisms of chemoresistance to alkylating agents in malignant glioma.
    Clin Cancer Res. 2008;14:2900-8.
    PubMed     Related articles    Abstract available
    
    
    
53. SPENCE AM , Muzi M, Swanson KR, O'Sullivan F, et al
    Regional Hypoxia in Glioblastoma Multiforme Quantified with [18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy: Correlation with Time to Progression and Survival.
    Clin Cancer Res. 2008;14:2623-30.
    PubMed     Related articles    Abstract available
    
    
    April 2008
54. SMITH ER , Zurakowski D, Saad A, Scott RM, et al
    Urinary biomarkers predict brain tumor presence and response to therapy.
    Clin Cancer Res. 2008;14:2378-86.
    PubMed     Related articles    Abstract available
    
    
    
55. ULLRICH R , Backes H, Li H, Kracht L, et al
    Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.
    Clin Cancer Res. 2008;14:2049-55.
    PubMed     Related articles    Abstract available
    
    
    
56. ZHU X , Asa SL, Ezzat S
    Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia.
    Clin Cancer Res. 2008;14:1984-96.
    PubMed     Related articles    Abstract available
    
    
    March 2008
57. GILG AG , Tye SL, Tolliver LB, Wheeler WG, et al
    Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multipotent progenitors.
    Clin Cancer Res. 2008;14:1804-13.
    PubMed     Related articles    Abstract available
    
    
    
58. HUSZTHY PC , Goplen D, Thorsen F, Immervoll H, et al
    Oncolytic herpes simplex virus type-1 therapy in a highly infiltrative animal model of human glioblastoma.
    Clin Cancer Res. 2008;14:1571-80.
    PubMed     Related articles    Abstract available
    
    
    
59. CHIAPPORI AA , Haura E, Rodriguez FA, Boulware D, et al
    Phase I/II Study of Atrasentan, an Endothelin A Receptor Antagonist, in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Advanced Non-Small Cell Lung Cancer.
    Clin Cancer Res. 2008;14:1464-9.
    PubMed     Related articles    Abstract available
    
    
    February 2008
60. GURURANGAN S , Turner CD, Stewart CF, O'Shaughnessy M, et al
    Phase I Trial of VNP40101M (Cloretazine) in Children with Recurrent Brain Tumors: A Pediatric Brain Tumor Consortium Study.
    Clin Cancer Res. 2008;14:1124-30.
    PubMed     Related articles    Abstract available
    
    
    
61. ROSSI A , Caracciolo V, Russo G, Reiss K, et al
    Medulloblastoma: From Molecular Pathology to Therapy.
    Clin Cancer Res. 2008;14:971-976.
    PubMed     Related articles    Abstract available
    
    
    
62. BRANDES AA , Franceschi E, Tosoni A, Hegi ME, et al
    Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments.
    Clin Cancer Res. 2008;14:957-60.
    PubMed     Related articles    Abstract available
    
    
    
63. YANG W , Wu G, Barth RF, Swindall MR, et al
    Molecular Targeting and Treatment of Composite EGFR and EGFRvIII-Positive Gliomas Using Boronated Monoclonal Antibodies.
    Clin Cancer Res. 2008;14:883-91.
    PubMed     Related articles    Abstract available
    
    
    
64. KIL WJ , Cerna D, Burgan WE, Beam K, et al
    In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide.
    Clin Cancer Res. 2008;14:931-8.
    PubMed     Related articles    Abstract available
    
    
    January 2008
65. YOSHIMOTO K , Dang J, Zhu S, Nathanson D, et al
    Development of a Real-time RT-PCR Assay for Detecting EGFRvIII in Glioblastoma Samples.
    Clin Cancer Res. 2008;14:488-493.
    PubMed     Related articles    Abstract available
    
    
    
66. GOW CH , Chien CR, Chang YL, Chiu YH, et al
    Radiotherapy in lung adenocarcinoma with brain metastases: effects of activating epidermal growth factor receptor mutations on clinical response.
    Clin Cancer Res. 2008;14:162-8.
    PubMed     Related articles    Abstract available
    
    
    
67. HUTTERER M , Knyazev P, Abate A, Reschke M, et al
    Axl and growth arrest specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme.
    Clin Cancer Res. 2008;14:130-8.
    PubMed     Related articles    Abstract available
    
    
    
68. ZEPPERNICK F , Ahmadi R, Campos B, Dictus C, et al
    Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients.
    Clin Cancer Res. 2008;14:123-9.
    PubMed     Related articles    Abstract available
    
    
    
69. KORSISAARI N , Ross J, Wu X, Kowanetz M, et al
    Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1.
    Clin Cancer Res. 2008;14:249-58.
    PubMed     Related articles    Abstract available
    
    
    
70. WYKOSKY J , Gibo DM, Stanton C, Debinski W, et al
    Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy.
    Clin Cancer Res. 2008;14:199-208.
    PubMed     Related articles    Abstract available
    
    
    December 2007
71. LAMFERS ML , Idema S, Bosscher L, Heukelom S, et al
    Differential Effects of Combined Ad5-{Delta}24RGD and Radiation Therapy in In vitro versus In vivo Models of Malignant Glioma.
    Clin Cancer Res. 2007;13:7451-7458.
    PubMed     Related articles    Abstract available
    
    
    
72. KUHN JG , Chang SM, Wen PY, Cloughesy TF, et al
    Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma.
    Clin Cancer Res. 2007;13:7401-6.
    PubMed     Related articles    Abstract available
    
    
    
73. SHIRAHATA M , Iwao-Koizumi K, Saito S, Ueno N, et al
    Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis.
    Clin Cancer Res. 2007;13:7341-56.
    PubMed     Related articles    Abstract available
    
    
    
74. JIANG X , Lu X, Liu R, Zhang F, et al
    HLA Tetramer Based Artificial Antigen-Presenting Cells Efficiently Stimulate CTLs Specific for Malignant Glioma.
    Clin Cancer Res. 2007;13:7329-34.
    PubMed     Related articles    Abstract available
    
    
    
75. LIU C , Sarkaria JN, Petell CA, Paraskevakou G, et al
    Combination of Measles Virus Virotherapy and Radiation Therapy Has Synergistic Activity in the Treatment of Glioblastoma Multiforme.
    Clin Cancer Res. 2007;13:7155-7165.
    PubMed     Related articles    Abstract available
    
    
    
76. LOGHIN ME , Prados MD, Wen P, Junck L, et al
    Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study.
    Clin Cancer Res. 2007;13:7133-8.
    PubMed     Related articles    Abstract available
    
    
    
77. LO KC , Ma C, Bundy BN, Pomeroy SL, et al
    Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma.
    Clin Cancer Res. 2007;13:7022-8.
    PubMed     Related articles    Abstract available
    
    
    
78. MANGIOLA A , Lama G, Giannitelli C, De Bonis P, et al
    Stem Cell Marker Nestin and c-Jun NH2-Terminal Kinases in Tumor and Peritumor Areas of Glioblastoma Multiforme: Possible Prognostic Implications.
    Clin Cancer Res. 2007;13:6970-6977.
    PubMed     Related articles    Abstract available
    
    
    
79. FINE HA , Kim L, Albert PS, Duic JP, et al
    A phase I trial of lenalidomide in patients with recurrent primary central nervous system tumors.
    Clin Cancer Res. 2007;13:7101-6.
    PubMed     Related articles    Abstract available
    
    
    
80. WELLER M , Berger H, Hartmann C, Schramm J, et al
    Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?
    Clin Cancer Res. 2007;13:6933-7.
    PubMed     Related articles    Abstract available
    
    
    November 2007
81. MILETIC H , Fischer YH, Giroglou T, Rueger MA, et al
    Normal Brain Cells Contribute to the Bystander Effect in Suicide Gene Therapy of Malignant Glioma.
    Clin Cancer Res. 2007;13:6761-6768.
    PubMed     Related articles    Abstract available
    
    
    
82. BRONISCER A , Gururangan S, Macdonald TJ, Goldman S, et al
    Phase I Trial of Single-Dose Temozolomide and Continuous Administration of O6-Benzylguanine in Children with Brain Tumors: a Pediatric Brain Tumor Consortium Report.
    Clin Cancer Res. 2007;13:6712-6718.
    PubMed     Related articles    Abstract available
    
    
    
83. AOKI H , Yokoyama T, Fujiwara K, Tari AM, et al
    Phosphorylated Pak1 Level in the Cytoplasm Correlates with Shorter Survival Time in Patients with Glioblastoma.
    Clin Cancer Res. 2007;13:6603-6609.
    PubMed     Related articles    Abstract available
    
    
    
84. KOSCHNY R , Sykora J, Walczak H, Ganten TM, et al
    Bortezomib-Mediated Up-Regulation of TRAIL-R1 and TRAIL-R2 Is Not Necessary for but Contributes to Sensitization of Primary Human Glioma Cells to TRAIL.
    Clin Cancer Res. 2007;13:6541-6542.
    PubMed     Related articles   
    
    
    
85. HAQUE T , Faury D, Albrecht S, Lopez-Aguilar E, et al
    Gene Expression Profiling from Formalin-Fixed Paraffin-Embedded Tumors of Pediatric Glioblastoma.
    Clin Cancer Res. 2007;13:6284-6292.
    PubMed     Related articles    Abstract available
    
    
    
86. KYRITSIS AP , Tachmazoglou F, Rao JS, Puduvalli VK, et al
    Bortezomib sensitizes human astrocytoma cells to tumor necrosis factor related apoptosis-inducing ligand induced apoptosis.
    Clin Cancer Res. 2007;13:6540-1.
    PubMed     Related articles   
    
    
    October 2007
87. YAMINI B , Yu X, Pytel P, Galanopoulos N, et al
    Adenovirally delivered tumor necrosis factor-alpha improves the antiglioma efficacy of concomitant radiation and temozolomide therapy.
    Clin Cancer Res. 2007;13:6217-23.
    PubMed     Related articles    Abstract available
    
    
    
88. IKEGAKI N , Gotoh T, Kung B, Riceberg JS, et al
    De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene.
    Clin Cancer Res. 2007;13:6001-9.
    PubMed     Related articles    Abstract available
    
    
    August 2007
89. ROUSSEAU J , Boudou C, Barth RF, Balosso J, et al
    Enhanced Survival and Cure of F98 Glioma Bearing Rats following Intracerebral Delivery of Carboplatin in Combination with Photon Irradiation.
    Clin Cancer Res. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    July 2007
90. ZHOU Q , Guo P, Kruh GD, Vicini P, et al
    Predicting human tumor drug concentrations from a preclinical pharmacokinetic model of temozolomide brain disposition.
    Clin Cancer Res. 2007;13:4271-9.
    PubMed     Related articles    Abstract available
    
    
    
91. GONDI CS , Lakka SS, Dinh DH, Olivero WC, et al
    Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice.
    Clin Cancer Res. 2007;13:4051-60.
    PubMed     Related articles    Abstract available
    
    
    
92. KOBAYASHI T , Masumoto J, Tada T, Nomiyama T, et al
    Prognostic significance of the immunohistochemical staining of cleaved caspase-3, an activated form of caspase-3, in gliomas.
    Clin Cancer Res. 2007;13:3868-74.
    PubMed     Related articles    Abstract available
    
    
    June 2007
93. EWEND MG , Brem S, Gilbert M, Goodkin R, et al
    Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local control.
    Clin Cancer Res. 2007;13:3637-41.
    PubMed     Related articles    Abstract available
    
    
    
94. GEORGE J , Gondi CS, Dinh DH, Gujrati M, et al
    Restoration of tissue factor pathway inhibitor-2 in a human glioblastoma cell line triggers caspase-mediated pathway and apoptosis.
    Clin Cancer Res. 2007;13:3507-17.
    PubMed     Related articles    Abstract available
    
    
    
95. BARNETT JA , Urbauer DL, Murray GI, Fuller GN, et al
    Cytochrome P450 1B1 expression in glial cell tumors: an immunotherapeutic target.
    Clin Cancer Res. 2007;13:3559-67.
    PubMed     Related articles    Abstract available
    
    
    
96. KOSCHNY R , Holland H, Sykora J, Haas TL, et al
    Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Clin Cancer Res. 2007;13:3403-12.
    PubMed     Related articles    Abstract available
    
    
    May 2007
97. MCCONVILLE P , Hambardzumyan D, Moody JB, Leopold WR, et al
    Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma.
    Clin Cancer Res. 2007;13:2897-904.
    PubMed     Related articles    Abstract available
    
    
    
98. RUTKOWSKI S , von Bueren A, von Hoff K, Hartmann W, et al
    Prognostic Relevance of Clinical and Biological Risk Factors in Childhood Medulloblastoma: Results of Patients Treated in the Prospective Multicenter Trial HIT'91.
    Clin Cancer Res. 2007;13:2651-7.
    PubMed     Related articles    Abstract available
    
    
    
99. COSTA BM , Ferreira P, Costa S, Canedo P, et al
    Association between Functional EGF+61 Polymorphism and Glioma Risk.
    Clin Cancer Res. 2007;13:2621-6.
    PubMed     Related articles    Abstract available
    
    
    
100. EOLI M , Menghi F, Bruzzone MG, De Simone T, et al
     Methylation of O6-Methylguanine DNA Methyltransferase and Loss of Heterozygosity on 19q and/or 17p Are Overlapping Features of Secondary Glioblastomas with Prolonged Survival.
     Clin Cancer Res. 2007;13:2606-13.
     PubMed     Related articles    Abstract available
     
     
     
101. CARLSON MR , Pope WB, Horvath S, Braunstein JG, et al
     Relationship between Survival and Edema in Malignant Gliomas: Role of Vascular Endothelial Growth Factor and Neuronal Pentraxin 2.
     Clin Cancer Res. 2007;13:2592-2598.
     PubMed     Related articles    Abstract available
     
     
     
102. FEDELE M , De Martino I, Pivonello R, Ciarmiello A, et al
     SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas.
     Clin Cancer Res. 2007;13:2738-44.
     PubMed     Related articles    Abstract available
     
     
     April 2007
103. GILLESPIE DL , Whang K, Ragel BT, Flynn JR, et al
     Silencing of Hypoxia Inducible Factor-1{alpha} by RNA Interference Attenuates Human Glioma Cell Growth In vivo.
     Clin Cancer Res. 2007;13:2441-8.
     PubMed     Related articles    Abstract available
     
     
     
104. ZHOU H , Miki R, Eeva M, Fike FM, et al
     Reciprocal Regulation of SOCS 1 and SOCS3 Enhances Resistance to Ionizing Radiation in Glioblastoma Multiforme.
     Clin Cancer Res. 2007;13:2344-2353.
     PubMed     Related articles    Abstract available
     
     
     
105. SOUSSAIN C , Muldoon LL, Varallyay C, Jahnke K, et al
     Characterization and magnetic resonance imaging of a rat model of human B-cell central nervous system lymphoma.
     Clin Cancer Res. 2007;13:2504-11.
     PubMed     Related articles    Abstract available
     
     
     March 2007
106. DEEKEN JF , Loscher W
     The blood-brain barrier and cancer: transporters, treatment, and Trojan horses.
     Clin Cancer Res. 2007;13:1663-74.
     PubMed     Related articles    Abstract available
     
     
     
107. PALMIERI D , Chambers AF, Felding-Habermann B, Huang S, et al
     The biology of metastasis to a sanctuary site.
     Clin Cancer Res. 2007;13:1656-62.
     PubMed     Related articles    Abstract available
     
     
     
108. ARAGON-CHING JB , Zujewski JA
     CNS metastasis: an old problem in a new guise.
     Clin Cancer Res. 2007;13:1644-7.
     PubMed     Related articles    Abstract available
     
     
     
109. BRONISCER A , Panetta JC, O'Shaughnessy M, Fraga C, et al
     Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420.
     Clin Cancer Res. 2007;13:1511-5.
     PubMed     Related articles    Abstract available
     
     
     
110. MARTIN DT , Gendron RL, Jarzembowski JA, Perry A, et al
     Tubedown expression correlates with the differentiation status and aggressiveness of neuroblastic tumors.
     Clin Cancer Res. 2007;13:1480-7.
     PubMed     Related articles    Abstract available
     
     
     
111. SCHRAMM A , Vandesompele J, Schulte JH, Dreesmann S, et al
     Translating expression profiling into a clinically feasible test to predict neuroblastoma outcome.
     Clin Cancer Res. 2007;13:1459-65.
     PubMed     Related articles    Abstract available
     
     
     
112. LAVON I , Zrihan D, Zelikovitch B, Fellig Y, et al
     Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas.
     Clin Cancer Res. 2007;13:1429-37.
     PubMed     Related articles    Abstract available
     
     
     January 2007
113. MELLINGHOFF IK , Cloughesy TF, Mischel PS
     PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors.
     Clin Cancer Res. 2007;13.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: